Skip to main content
Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry
Presenter: Gill Buchanan
Up Next
Presenter: A. Rene
More slides +
Presenter: Imdad Ahmed
Presenter: Guy Friedrich